# A CLOSED SYSTEM FOR PATHOGEN REDUCTION OF RED BLOOD CELLS FOR TRANSFUSION

> **NIH NIH R44** · ZATA PHARMACEUTICALS, INC. · 2021 · $1,169,287


## Key facts

- **NIH application ID:** 10126895
- **Project number:** 5R44HL145783-03
- **Recipient organization:** ZATA PHARMACEUTICALS, INC.
- **Principal Investigator:** David R Tabatadze
- **Activity code:** R44 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $1,169,287
- **Award type:** 5
- **Project period:** 2019-03-01 → 2023-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10126895

## Citation

> US National Institutes of Health, RePORTER application 10126895, A CLOSED SYSTEM FOR PATHOGEN REDUCTION OF RED BLOOD CELLS FOR TRANSFUSION (5R44HL145783-03). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10126895. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*